We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000895:SZSEHenan Shuanghui Investment & Development Co.,Ltd. Analysis

Data as of 2026-05-22 - not real-time

CN¥25.73

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Henan Shuanghui Investment & Development is trading at CNY 25.73, roughly 31% above its DCF‑derived fair value of CNY 19.59, suggesting the market may be overpaying for the stock. Technical signals are mixed: the 14‑day RSI sits at 29, indicating oversold conditions, while the MACD remains in a bearish configuration and the price is below both the 20‑day (27.33) and 50‑day (27.79) moving averages. Liquidity is waning, with a decreasing volume trend despite a solid market cap of CNY 89.1 bn, and the beta of 0.04 points to extremely low systematic risk. The company offers an attractive dividend yield of 6.18%, but the payout ratio is a lofty 92% and free cash flow is negative, raising concerns about sustainability. Revenue growth is modest at 2.1% and margins are thin (gross margin 18.3%, operating margin 12.8%), while debt‑to‑equity stands at 60%, indicating moderate leverage. Given the overvaluation, cash‑flow pressure, and defensive sector backdrop, investors should approach the stock cautiously, weighing the short‑term upside from technical oversold signals against longer‑term fundamentals that appear stretched.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicating oversold conditions
  • Price hovering near strong support at CNY 25.6
  • Bearish MACD histogram suggesting limited upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High dividend yield but unsustainable payout ratio
  • Valuation above DCF fair value
  • Negative free cash flow limiting reinvestment

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation relative to intrinsic value
  • Persistent cash‑flow deficits
  • Moderate leverage in a low‑growth consumer defensive industry

Key Metrics & Analysis

Financial Health

Revenue Growth2.10%
Profit Margin8.80%
P/E Ratio16.9
ROE23.44%
ROA9.84%
Debt/Equity60.40
P/B Ratio3.9
Op. Cash FlowCN¥7.5B
Free Cash FlowCN¥-1295037184

Technical Analysis

TrendNeutral
RSI29.2
SupportCN¥25.60
ResistanceCN¥29.28
MA 20CN¥27.33
MA 50CN¥27.79
MA 200CN¥26.37
MACDBearish
VolumeDecreasing
Fear & Greed Index91.29

Valuation

Fair ValueCN¥19.59
Target PriceCN¥28.71
Upside/Downside11.57%
GradeOvervalued
TypeValue
Dividend Yield6.18%

Risk Assessment

Beta0.04
Volatility22.03%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.